Exploration of transcutaneous vagus nerve stimulation as a treatment option for adjuvant cancer and heart failure therapy
Niklas Frank , Michiaki Nagai , Carola Y. Förster
Exploration of Neuroprotective Therapy ›› 2023, Vol. 3 ›› Issue (5) : 363 -397.
Vagus nerve stimulation (VNS) has gained prominence in the treatment of various clinical disorders such as migraine, depression, and tinnitus. Based on increased scientific knowledge of the VNS and insights into the vagus nerve (VN) function and anatomy/conduction, robust treatment approaches have been developed. There are both noninvasive and invasive VNS (iVNS) techniques. Currently, only iVNS techniques are approved by the US Food and Drug Administration (FDA). In contrast, transcutaneous VNS (tVNS) is a new treatment option that is receiving increasing attention. The tVNS application uses the cutaneous distribution of afferent VN fibers in the auricle, the auricular branch of the VN (ABVN), or in the neck, the cervical branch of the VN (CBVN). However, the tVNS technique has not yet been sufficiently researched in its application and mode of action to be used clinically on a large scale. Moreover, the stimulation parameters of the VN vary widely in different studies. Despite the growing number of research papers on this topic, more coherence in neurostimulation research and neuroanatomical basis is needed. The aim of this review is to highlight new clinical treatment options based on existing clinically applied treatment options. In this article, current clinical applications of tVNS are analyzed and important stimulation parameters are highlighted. Based on this data, useful new tVNS therapies are recommended. The focus will be placed on the study of inflammatory processes associated with cancer and on applications to cardiovascular events such as heart failure.
Vagus nerve / transcutaneous vagus nerve stimulation / inflammation / cancer / heart failure with preserved ejection fraction
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
Howland RH. Vagus nerve stimulation. Curr Behav Neurosci Rep. 2014; 1: 64-73. |
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
Brenner B, Ericson T, |
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
Stavrakis S, Humphrey MB, Scherlag BJ, |
| [69] |
Steenbergen L, Sellaro R, |
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
|
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
Stavrakis S, Stoner JA, Humphrey MB, Morris L, Filiberti A, Reynolds JC, |
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
Tran N, Asad Z, Elkholey K, Scherlag BJ, Po SS, |
| [95] |
|
| [96] |
|
| [97] |
Fisher H, Stowell J, Garcia R, Sclocco R, Goldstein J, Napadow V, |
| [98] |
|
| [99] |
|
| [100] |
|
| [101] |
|
| [102] |
|
| [103] |
Nagai M, Kato M, |
| [104] |
|
| [105] |
|
| [106] |
|
| [107] |
|
| [108] |
|
| [109] |
|
| [110] |
|
| [111] |
|
| [112] |
|
| [113] |
|
| [114] |
|
| [115] |
|
| [116] |
|
| [117] |
|
| [118] |
|
| [119] |
|
| [120] |
|
| [121] |
|
| [122] |
|
| [123] |
Vanneste S, Martin J, |
| [124] |
GBD 2016 Epilepsy Collaborators. Global, regional, and national burden of epilepsy, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019; 18: 357-75. |
| [125] |
|
| [126] |
|
| [127] |
|
| [128] |
|
| [129] |
|
| [130] |
|
| [131] |
Henry TR. Therapeutic mechanisms of vagus nerve stimulation. Neurology. 2002; 59: S3-14. |
| [132] |
|
| [133] |
|
| [134] |
|
| [135] |
Coppola G, Vandenheede M, Di Clemente L, Ambrosini A, Fumal A, De Pasqua V, |
| [136] |
|
| [137] |
|
| [138] |
Tracey KJ. Reflex control of immunity. Nat Rev Immunol. 2009; 9: 418-28. |
| [139] |
|
| [140] |
|
| [141] |
|
| [142] |
|
| [143] |
|
| [144] |
|
| [145] |
|
| [146] |
|
| [147] |
|
| [148] |
|
| [149] |
|
| [150] |
|
| [151] |
|
| [152] |
Global Burden of Disease Cancer Collaboration; |
| [153] |
|
| [154] |
|
| [155] |
|
| [156] |
|
| [157] |
|
| [158] |
|
| [159] |
Kamiya A, Hiyama T, Fujimura A, |
| [160] |
|
| [161] |
|
| [162] |
|
| [163] |
|
| [164] |
|
| [165] |
|
| [166] |
|
| [167] |
|
| [168] |
|
| [169] |
|
| [170] |
|
| [171] |
Agelaki S, Tsatsanis C, Gravanis A, |
| [172] |
|
| [173] |
|
| [174] |
|
| [175] |
|
| [176] |
|
| [177] |
|
| [178] |
|
| [179] |
|
| [180] |
|
| [181] |
Authors/Task Force Members; |
| [182] |
Grassi G, Colombo M, Seravalle G, Spaziani D, |
| [183] |
|
| [184] |
Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension. 1989; 14: 177-83. |
| [185] |
|
| [186] |
|
| [187] |
Stavrakis S, Elkholey K, Morris L, Niewiadomska M, |
| [188] |
|
| [189] |
|
| [190] |
|
| [191] |
|
| [192] |
|
| [193] |
Guyton AC. Blood pressure control-special role of the kidneys and body fluids. Science. 1991; 252: 1813-6. |
| [194] |
|
| [195] |
|
| [196] |
Hall JE. The kidney, hypertension, and obesity. Hypertension. 2003; 41: 625-33. |
| [197] |
|
| [198] |
|
| [199] |
Nagaoka A, |
| [200] |
|
| [201] |
|
| [202] |
|
| [203] |
|
| [204] |
|
| [205] |
|
| [206] |
|
| [207] |
|
| [208] |
Nagai M, Dote K, Kato M, Sasaki S, Oda N, Förster CY. Case report: SGLT2i, transcutaneous vagus nerve stimulation, and their effects on intrarenal venous flow pattern in HFpEF. Front Neurosci. 2022; 16: 999831. |
| [209] |
|
| [210] |
Nagai M, Dote K, Kato M, Sasaki S, Oda N, |
| [211] |
|
| [212] |
|
| [213] |
|
| [214] |
|
| [215] |
|
| [216] |
|
| [217] |
|
/
| 〈 |
|
〉 |